Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the safety, tolerability, and antileukemic activity of Debio 1562M in adults with acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Debio 1562M

Snippet

Sponsor: Debiopharm International SA | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING